Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

600,000 Seniors Have Signed Up for Obesity Drugs Under New Medicare Program

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

Hims & Hers Offers GLP-1s, Men's Health Treatments in Australia

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

Time-Restricted Eating Helps Sustain Weight Loss

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

GLP-1 Weight Loss Drugs Effective Even At Low Starter Doses

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Thyroid Shifts in Midlife Women? Blame Aging, Not Menopause

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

News All Time

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

T2D Linked to Brain Thinning in Older Adults

Older adults with type 2 diabetes have faster cortical thinning in several brain regions and greater decline in processing speed, a study finds.

Surgery Underused in Primary Hyperparathyroidism Care

Two thirds of patients with primary hyperparathyroidism have or develop end-organ damage, but only 20% undergo parathyroidectomy, a national cohort study shows.

The Hidden Cost of Daily Steroids in Duchenne Dystrophy

Boys with Duchenne muscular dystrophy on daily corticosteroids maintained walking ability 4 years longer than those on intermittent treatment, but at what cost to their bone health and growth?

More Water, More Food; More Spice, Less Food

Two studies challenge conventional weight-loss advice.

1 in 4 Regain Significant Weight After Bariatric Surgery

Most patients maintain their weight loss for years after bariatric surgery, but about 1 in 4 regain significant weight, with inappropriate eating habits linked to weight regain.

The Medicare GLP-1 Discount Has One Big Catch

About 1 in 5 American adults have taken a GLP-1 medication, and most of them, including those with health insurance, say the drugs are difficult to afford.

Pancreatic Cancer Referral Rate Low in Diabetes, Weight Loss

Among adults aged 60 years or older with new-onset diabetes and unexplained weight loss, referrals and abdominal imaging for suspected pancreatic cancer appear low in primary care.

Remote Program Aids Obesity Medication Access

Pharmacists and navigators can expand obesity drug access without doctor visits — but drug shortages, insurance hurdles, and paperwork, not patient willingness, are the real bottlenecks to scale.

India Wanted Red Flags on Chip Packets and Soda. Big Food Fought Back

A can of Fanta sold in London has 63 calories. Buy the same brand in India, and it contains three times as much sugar. It also includes artificial dye, whose presence in...

Diabetes Prevention Starts Earlier Than Thought

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood, and adulthood.

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.